A Study of Daridorexant in Chinese Patients With Insomnia Disorder

Summary

The primary purpose of this study is to assess the efficacy and safety of 50 mg daridorexant in adult and elderly chinese patients with insomnia disorder. Efficacy will be evaluated on objective and subjective sleep parameters .

Timeline

Start

2023-08-28

Primary completion

2024-04-12

Completion

2024-05-10

Publications

• Huang Z, Wang H, Zhang B, Li C, Wang J, Xu L, Xu Q, Chen J, Xiao L, Wang Z, Wang B, Jiang Y, Liu Y, Yuan C, Ma Q, Wu J, Liu X, Huang Y, Cui H, Wang F, Wang Y. Efficacy and safety of daridorexant in Chinese patients with insomnia disorder: a multicenter, randomized, double-blind, placebo-controlled phase III clinical trial. Sleep. 2025 Dec 11;48(12):zsaf170. doi: 10.1093/sleep/zsaf170.

Drugs

Indications